251 related articles for article (PubMed ID: 31749286)
41. Tendon transposition in the surgical management of a soft tissue sarcoma of the limb.
Garden OA; Tuck ME
Vet Rec; 1993 Dec 18-25; 133(25-26):621-3. PubMed ID: 8141916
[No Abstract] [Full Text] [Related]
42. Radiation treatment for incompletely resected soft-tissue sarcomas in dogs.
McKnight JA; Mauldin GN; McEntee MC; Meleo KA; Patnaik AK
J Am Vet Med Assoc; 2000 Jul; 217(2):205-10. PubMed ID: 10909459
[TBL] [Abstract][Full Text] [Related]
43. Canine Cutaneous and Subcutaneous Soft Tissue Sarcoma: An Evidence-Based Review of Case Management.
Hohenhaus AE; Kelsey JL; Haddad J; Barber L; Palmisano M; Farrelly J; Soucy A
J Am Anim Hosp Assoc; 2016; 52(2):77-89. PubMed ID: 26808432
[TBL] [Abstract][Full Text] [Related]
44. Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.
Milovancev M; Townsend KL; Tuohy JL; Gorman E; Bracha S; Curran KM; Russell DS
Vet Surg; 2020 Jan; 49(1):96-105. PubMed ID: 31044443
[TBL] [Abstract][Full Text] [Related]
45. Expression of fibroblast growth factor 23 by canine soft tissue sarcomas.
Hardcastle MR; Dittmer KE
Vet Comp Oncol; 2016 Sep; 14(3):306-17. PubMed ID: 24923416
[TBL] [Abstract][Full Text] [Related]
46. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
Kopp HG; Patel S; Brücher B; Hartmann JT
Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic accuracy of pre-treatment biopsy for grading soft tissue sarcomas in dogs.
Perry JA; Culp WT; Dailey DD; Eickhoff JC; Kamstock DA; Thamm DH
Vet Comp Oncol; 2014 Jun; 12(2):106-13. PubMed ID: 22617002
[TBL] [Abstract][Full Text] [Related]
48. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
Todd R; Lunec J
Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
[TBL] [Abstract][Full Text] [Related]
49. Developing a translational murine-to-canine pathway for an IL-2/agonist anti-CD40 antibody cancer immunotherapy.
Proksch SF; Matthysen CP; Jardine JE; Wyatt KM; Finlay JR; Nelson DJ
Vet Comp Oncol; 2022 Sep; 20(3):602-612. PubMed ID: 35315197
[TBL] [Abstract][Full Text] [Related]
50. The Role of Immunotherapy in the Management of Soft Tissue Sarcomas: Current Landscape and Future Outlook.
Banks LB; D'Angelo SP
J Natl Compr Canc Netw; 2022 Jul; 20(7):834-844. PubMed ID: 35830892
[TBL] [Abstract][Full Text] [Related]
51. Radiation-induced osteosarcoma in dogs after external beam or intraoperative radiation therapy.
Gillette SM; Gillette EL; Powers BE; Withrow SJ
Cancer Res; 1990 Jan; 50(1):54-7. PubMed ID: 2403417
[TBL] [Abstract][Full Text] [Related]
52. Characterizing Microscopical Invasion Patterns in Canine Mast Cell Tumours and Soft Tissue Sarcomas.
Russell DS; Townsend KL; Gorman E; Bracha S; Curran K; Milovancev M
J Comp Pathol; 2017 Nov; 157(4):231-240. PubMed ID: 29169616
[TBL] [Abstract][Full Text] [Related]
53. Emerging trends in immunotherapy for pediatric sarcomas.
Dyson KA; Stover BD; Grippin A; Mendez-Gomez HR; Lagmay J; Mitchell DA; Sayour EJ
J Hematol Oncol; 2019 Jul; 12(1):78. PubMed ID: 31311607
[TBL] [Abstract][Full Text] [Related]
54. Current and advancing systemic treatment options for soft tissue sarcomas.
Harris SJ; Benson C; Jones RL
Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
[TBL] [Abstract][Full Text] [Related]
55. Exploring the landscape of immunotherapy approaches in sarcomas.
Pilavaki P; Panagi M; Arifi S; Jones RL; Stylianopoulos T; Constantinidou A
Front Oncol; 2022; 12():1069963. PubMed ID: 36686827
[TBL] [Abstract][Full Text] [Related]
56. Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia.
Poulson JM; Vujaskovic Z; Gaskin AA; Larue SM; Meyer RE; Prescott DM; Samulski TV; Thrall DE; Dewhirst MW
Int J Hyperthermia; 2004 Aug; 20(5):477-89. PubMed ID: 15277021
[TBL] [Abstract][Full Text] [Related]
57. A role for maintenance therapy in managing sarcoma.
Ray-Coquard I; Le Cesne A
Cancer Treat Rev; 2012 Aug; 38(5):368-78. PubMed ID: 21843915
[TBL] [Abstract][Full Text] [Related]
58. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas.
McCarthy EF
Iowa Orthop J; 2006; 26():154-8. PubMed ID: 16789469
[TBL] [Abstract][Full Text] [Related]
59. Apoptotic response of irradiated T-lymphocytes. An epidemiologic study in canine radiotherapy patients.
Stankeová S; Crompton NE; Blattmann H; Theiler P; Emery GC; Roos M; Kaser-Hotz B
Strahlenther Onkol; 2003 Nov; 179(11):779-86. PubMed ID: 14605749
[TBL] [Abstract][Full Text] [Related]
60. Soft tissue sarcomas in adults. Surgical, radiologic and cytotoxic treatment.
Arnoldi C; Johansen H; Mouridsen HT
Acta Radiol Oncol; 1984; 23(2-3):169-75. PubMed ID: 6331087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
